Alteplase Dose PowerPoint PPT Presentations
All Time
Recommended
Randomised double-blind placebo-controlled trial of thrombolytic therapy with ... A bolus of 10% of the total dose was given over 1-2 min, followed by a 60 min ...
| PowerPoint PPT presentation | free to view
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine * * Research Question Does intravenous tPA (Alteplase) when given only within 3 hours of the onset of ...
| PowerPoint PPT presentation | free to download
PHARMACEUTICAL CARE ISSUES IN CARDIOLOGY BY: BASARIAH BT NAINA B.PHARM(HONS)M.PHARM(CLINICAL) Isosorbide Mononitrate Adv of ISMO less dosage fluctuation because of ...
| PowerPoint PPT presentation | free to view
Emergency Medications Dr. Zohair Alaseri, MD FRCPc, Emergency Medicine FRCPc, Critical Care Medicine Intensivest and Emergency Medicine Consultant
| PowerPoint PPT presentation | free to view
and Update on New ACLS Guidelines Krista Piekos, Pharm.D. Clinical Pharmacy Specialist - Critical Care Harper University Hospital Adjunct Assistant Professor
| PowerPoint PPT presentation | free to download
Emergency Drug Review UHHS BMH Paramedic Training Program Ronald Pristera EMT-P Objectives This will be a quick overview You should have been studying your drug ...
| PowerPoint PPT presentation | free to view
ACLS Pharmacology Jeremy Maddux NREMTP * * Summary To obtain a full understanding of ACLS pharmacology requires constant review of: Indications & Actions (When & Why?)
| PowerPoint PPT presentation | free to view
Classification of Ischemic Heart Disease Acute coronary syndromes 1) Drugs that Affect Blood Coagulation Used in the prevention and management of thrombotic and ...
| PowerPoint PPT presentation | free to download
Novel Uses for Antithrombotics Jim Holliman, M.D., F.A.C.E.P. Program Manager Afghanistan Health Care Sector Reconstruction Project Center for Disaster & Humanitarian ...
| PowerPoint PPT presentation | free to view
Top Ten Drugs or Classes in the Intensive Care Unit
| PowerPoint PPT presentation | free to view
Title: THROMBOEMBOLIC DISORDERS Author: Kal Ganesan Last modified by: user Created Date: 3/18/2004 4:01:28 PM Document presentation format: Apresenta o no ecr
| PowerPoint PPT presentation | free to download
She has history of Af with RVR on regular medicine control. ... extremity is subdivided into either calf vein or proximal vein (popliteal, ...
| PowerPoint PPT presentation | free to view
Title: NEJM 1996: TASMAN and North-American studies Main results Author: Prandoni Paolo Last modified by: pippo Created Date: 1/7/2001 2:57:39 PM
| PowerPoint PPT presentation | free to view
THROMBOPHILIA DVT PROPHYLAXIS VTE MANAGEMENT DR. ASHISH Moderator: DR. MEERA KHARBANDA www.anaesthesia.co.in anaesthesia.co.in@gmail.com
| PowerPoint PPT presentation | free to download
Pharmacological management of Ischaemic heart disease and acute myocardial infarction Hamid Shamsolkottabi MD Cardiologist Sina Heart Center, Esfahan, IRAN
| PowerPoint PPT presentation | free to view
... results make ACS fairly protocol driven www.NICE.org.uk www.clinicalevidence.con Cochrane data base Guidelines for the management ... Dyslipidaemia - more chronic ...
| PowerPoint PPT presentation | free to view
... results make ACS fairly protocol driven www.NICE.org.uk www.clinicalevidence.con Cochrane data base Guidelines for the management of acute coronary syndromes ...
| PowerPoint PPT presentation | free to view
(PRICE LOWERED) Seriously the Easiest Way to Learn Pharmacology
| PowerPoint PPT presentation | free to download
Effect of CPB on coagulation. Medical conditions that affect it. Tests of coagulation ... Effect of CPB on coagulation. Soluble factors. Consumption. denatured ...
| PowerPoint PPT presentation | free to view
Place two 18 gauge cannulas in large veins, preferably in both antecubital fossa ... Place a cannula in each antecubital fossa. 1 for treatment and 1 for ...
| PowerPoint PPT presentation | free to view
Identify purpose and use of anticoagulant, antiplatelet, and ... Visual disturbances such as photophobia & altered color perception may be a sign ...
| PowerPoint PPT presentation | free to view
Haemophilia. Christmas disease. Von Willebrands. Drugs. Discussed ... Haemophilia / Christmas disease. Factor X11 Factor X11a. Factor X1 Factor X1a factor V111 ...
| PowerPoint PPT presentation | free to view
American Heart Association, Inc. Acute Coronary Syndromes: Case 2. Learning Objectives: ... American Heart Association, Inc. Acute Coronary Syndromes: Case 2 ...
| PowerPoint PPT presentation | free to view
Tout retard lors des soins pr hospitaliers repr sente un obstacle ... passe une thrombolyse par TDM 24 heures plus tard pour exclure la possibilit d ...
| PowerPoint PPT presentation | free to view
... post-operative bleeding due to its vasoconstrictive properties-cocaine addicts ... 7) Proper physical properties (water solubility and stability in ...
| PowerPoint PPT presentation | free to view
Pathophysiology of Thrombosis Thrombosis and Thrombolysis in Acute Coronary Syndromes Blood Components - Platelets Contain adhesive glycoproteins GP Ia binds ...
| PowerPoint PPT presentation | free to download
To emphasise problems associated with their use especially WARFARIN ... 65 amino acid protein from medicinal leech forms tight 1:1 complex with ...
| PowerPoint PPT presentation | free to view
No single bolus thrombolytic trial was adequately powered to detect a 30% excess ... Bolus thrombolytic agents are not associated with an efficacy advantage in terms ...
| PowerPoint PPT presentation | free to view
the platelet - white trombus - red trombus. Hemostasis: 1.adhesion and ... 1. Extrinsic koagulo-pathways - components ... inhibitor from the leech. ...
| PowerPoint PPT presentation | free to download
... acute coronary syndromes - transient ischaemic attack Aneurysm formation Aims of treatment Relieve symptoms Slow disease progression Reduce risk of acute ...
| PowerPoint PPT presentation | free to view
Methods and specific issues of the anticoagulant therapy Szabolcs Modok Dentistry, 4th year, Internal medicine
| PowerPoint PPT presentation | free to view
To emphasise problems associated with their use especially WARFARIN ... Warfarin blocks the vit K epoxide reductase step in this cycle. ...
| PowerPoint PPT presentation | free to view
Les anticoagulants IFSI 2 me ann e Christophe Bazin Plan du cours G n ralit s sur la coagulation Traitements Recommandations Conclusions G n ralit s sur la ...
| PowerPoint PPT presentation | free to view
Heparin Unfractionated heparin: Inhibits AT ...
| PowerPoint PPT presentation | free to download
Cardiac Pharmacology Overview Cardiovascular A & P Review Gross Anatomy Cellular Anatomy Drugs that affect the cardiac system Drugs That Affect the Cardiac System ...
| PowerPoint PPT presentation | free to view
Anticoagulants and Antiplatelets Presenter: Dr. Ashish Chakravarty MD student Moderator: Dr. Kavita Sharma Professor Dept. of Anesthesiology and Intensive Care,
| PowerPoint PPT presentation | free to download
Hint: Do not give aspirin / heparin during the first 24 hr ... Active internal bleeding within 21 days (except menses) Aortic dissection. History of CNS tumor ...
| PowerPoint PPT presentation | free to view
She has been in excellent health and returned 2 days ago ... Matthew B. Stanbrook, MD Brigham and Women's Hospital, Harvard Medical School. CT scan in P.E. ...
| PowerPoint PPT presentation | free to view
LES MEDICAMENTS DE L HEMOSTASE OBJECTIFS PEDAGOGIQUES : Citez les familles des m dicaments de l'h mostase Citez les diff rentes classes d A.T.C et les ...
| PowerPoint PPT presentation | free to download
... IDM, angor stable et instable, angioplastie coronaire transluminale Formes IV Syndrome coronarien aigu (IDM sans onde Q, angor instable) ...
| PowerPoint PPT presentation | free to download
U. O. CARDIOLOGIA con UTIC Lamezia Terme Preparazione farmacologica alla PTCA: STEMI Negli ospedali senza emodinamica Dott. Antonio Butera Lamezia Terme
| PowerPoint PPT presentation | free to view
Identify the uses and varying actions of these drugs. ... preparations include: ferrous fumarate, ferrous gluconate, ferrous sulfate, and iron dextran. ...
| PowerPoint PPT presentation | free to view
Atherosclerotic vascular disease AVD may manifest as: Coronary artery disease. Cerebrovascular disease. Peripheral vascular disease. Pathophysiology:
| PowerPoint PPT presentation | free to view
Pharmacoepidemiology in Pharmacy Practice This chapter discusses the incorporation of evidence-based medicine into clinical practice. Other areas to which pharmacists ...
| PowerPoint PPT presentation | free to view
Minor/improving symptoms. Major surgery. Seizure. Arterial puncture ... Mild stroke. 0-6 h (4:36)** 1.5 million u. streptokinase. France, UK. MAST-E (1992-94) ...
| PowerPoint PPT presentation | free to view
... weeks Both early and late administration Long Term Trials B-blockade given for 6-48 months Long Term Trials 31 trials 24,974 patients OR for mortality 0.77 ...
| PowerPoint PPT presentation | free to download
... of appetite, breast enlargement, skin rash, blurred vision, and ... Mr. Beaudoin is 73 years old admitted with CHF. He has been started on Digoxin 0.125mg. ...
| PowerPoint PPT presentation | free to view
HEMOSTASIA S RIE VERMELHA TRATAMENTO DE ANEMIA Bruna B. Medeiros ANEMIA DE DOEN A CR NICA Exemplos Infec es subagudas ou cr nicas Abscesso pulmonar, empiema ...
| PowerPoint PPT presentation | free to view
Most trials have not used a weight-based regimen ... Ask patient and observers most conservative time. Not time of last neurological worsening ...
| PowerPoint PPT presentation | free to view
Professor Kamal Eldin Hussein ElTahir. Department of Pharmacology, College of Pharmacy, ... In Canada: Food Additive. In France and Germany:As over the Counter ...
| PowerPoint PPT presentation | free to view
ST-elevation myocardial infarction: A report of the ACC/AHA Task Force on ... However, only a small fraction of these abnormalities cause symptomatic ischemia. ...
| PowerPoint PPT presentation | free to view
J Endovasc Ther. 2002;9:593-598 IVC Filters Randomised trial by Decousus1 Filters vs. LMW Heparin 2 Year follow up OR = 1.87 (also no mortality ...
| PowerPoint PPT presentation | free to view
World Rank Order of Disease Burden (DALY) Lower resp infection ... hypercholesterolemia sheer stress. infection? high homocysteine? ENDOTHELIAL DYSFUNCTION ...
| PowerPoint PPT presentation | free to view
Ultrasound of leg veins. DVT No DVT. PAgram if continued clinical suspicion ... complication of leg swelling can occur. anticoagulation is continued if ...
| PowerPoint PPT presentation | free to view
(Age-standardized mortality rate for men and women aged 30, about 1990) ... 'Extrapolation from the survival curves suggested that [Coreg] extended median ...
| PowerPoint PPT presentation | free to view
pseudo aneurysm. Arrhythmia: *Tachyarrhythmia's. supraventricular. ventricular *Brady arrhythmias ... Lv aneurysm. Lv thrombosis Arterial embolism. ADMIRAL ...
| PowerPoint PPT presentation | free to view
